5th Oct 2007 07:00
Hikma Pharmaceuticals Plc05 October 2007 Block Listing - Six Monthly Review Name of Company: Hikma Pharmaceuticals PLC Name of scheme: Hikma Pharmaceuticals PLC 2004 Stock Option Plan Period of return: From: 6 April 2007 To: 5 October 2007 Balance under block scheme: 1,719,400 ordinary shares of 10 pence each The amount by which the block scheme has Nilbeen increased, if the scheme has beenincreased since the date of the lastreturn: Number of securities issued/allotted 314,000 ordinary shares of 10 pence under scheme during period: each Balance under scheme not yet issued/ 1,405,400 ordinary shares of 10 penceallotted at end of period each Number and class of securities originally 166,537,951 ordinary shares of 10listed and the date of admission pence each originally listed on 1 November 2005 Total number of securities in issue at 169,451,407 ordinary shares of 10 the end of the period pence each - ENDS - Enquiries: Hikma Pharmaceuticals PLC +44 20 7399 2760Henry Knowles, Company SecretarySusan Ringdal, Investor Relations Director Notes to Editors About Hikma Hikma Pharmaceuticals PLC is a fast growing multinational group focused ondeveloping, manufacturing and marketing a broad range of both branded andnon-branded generic and in-licensed products. Hikma's operates through threebusinesses: "Branded", "Injectables" and "Generics", based principally in theMiddle East and North Africa ("MENA"), where it is a market leader and sellsacross 18 countries, the United States and Europe. In 2006, Hikma achievedrevenues of $317 million (2005 $262 million) and profit attributable toshareholders was $55 million (2005 $44 million). At 31 December 2006, the Grouphad over 2,400 employees. For news and other information, please visitwww.hikma.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Hikma Pharmaceuticals